Efficacy and safety of dulaglutide monotherapy compared with glimepiride in Chinese patients with type 2 diabetes: Post‐hoc analyses of a randomized, double‐blind, phase III study-Reference-Cited by-同舟云学术

Efficacy and safety of dulaglutide monotherapy compared with glimepiride in Chinese patients with type 2 diabetes: Post‐hoc analyses of a randomized, double‐blind, phase III study

Published:2019-06-13 Issue:1 Volume:11 Page:142-150
ISSN:2040-1116
Container-title:Journal of Diabetes Investigation
language:en
Short-container-title:J Diabetes Investig

Author:

Shi Li Xin¹,Liu Xiao Min²,Shi Yong Quan³,Li Quan Min⁴,Ma Jian Hua⁵,Li Yan Bing⁶^ORCID,Du Li Ying⁷,Wang Feng⁷,Chen Lu Lu⁸

Affiliation:

1. Department of Endocrinology and Metabolism Affiliated Hospital of Guizhou Medical University GuiyangChina

2. Department of Endocrinology First Affiliated Hospital of Harbin Medical University HarbinChina

3. Shanghai Changzheng Hospital ShanghaiChina

4. Beijing 262 Hospital BeijingChina

5. Nanjing First Hospital NanjingChina

6. The First Affiliated Hospital Sun‐Yat Sen University GuangzhouChina

7. Lilly Suzhou Pharmaceutical Co. Ltd. ShanghaiChina

8. Department of Endocrinology Union Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan China

Funder

Eli Lilly and Company

Publisher

Wiley

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdi.13075

Reference15 articles.

1. Diabetes in China: Epidemiology and Genetic Risk Factors and Their Clinical Utility in Personalized Medication

2. Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States

3. International Diabetes Federation.IDF Diabetes Atlas 8th edn.2017; Available from:http://www.diabetesatlas.orgAccessed June 2 2019.

4. A 24-week study to evaluate the efficacy and safety of once-weekly dulaglutide added on to glimepiride in type 2 diabetes (AWARD-8)

5. Efficacy and Safety of Dulaglutide Added Onto Pioglitazone and Metformin Versus Exenatide in Type 2 Diabetes in a Randomized Controlled Trial (AWARD-1)

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessment of Changes in Body Composition After 3 Months of Dulaglutide Treatment;Diabetes, Metabolic Syndrome and Obesity;2024-03

2. Comparative effect of ginger (an anti-inflammatory medicinal herb) and aspirin (a non-steroidal anti-inflammatory drug) on cytoprotection and body weight changes in male albino Wistar rats;Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale;2023-06-22

3. GLP-1 Receptor Agonists and Risk of Adverse Cerebrovascular Outcomes in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;The Journal of Clinical Endocrinology & Metabolism;2023-02-17

4. Effect of dulaglutide injection on weight beyond glycemic control: real-world observational study;Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale;2023-02-16

5. Efficacy and safety of dulaglutide compared with the first-line hypoglycemic drugs in Asian patients with type 2 diabetes: a systematic review and meta-analysis;Scientific Reports;2022-10-31